AN11--Multi-Omics Sequencing Services (Research Study Support)

The VA Pittsburgh Healthcare System is seeking a contractor to provide multi-omics sequencing and analysis services to support a research study on degenerative cervical myelopathy (DCM). The study aims to identify diagnostic biomarkers for DCM and develop more targeted and individualized treatment strategies. The contractor will be required to extract metabolites, proteins, and RNA from human plasma and whole blood, perform omics analysis, and provide raw and analyzed data. The contractor must also be able to process a large number of samples (120) in a single batch and provide high-quality data. • The contractor must have experience with discovery-based untargeted omics tools and be able to detect subtle variations between similar spinal cord diseases. • The contractor must be able to provide a complete pipeline for the study's multi-omics needs, including sample prep and complete data analysis. • The contractor must be low-cost and high-throughput, as the study has a small pilot funding (less than 50K) and a short-time frame (by September 30, 2026).